Xianwei Wang

Dr. Xianwei Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
CGChanglin Gao
Changlin Gao
HZHaoran Zhang
Haoran Zhang
XWXianwei Wang
Xianwei Wang
Ferroptosis is a non-apoptotic form of regulated cell death characterized by iron accumulation and uncontrolled lipid peroxidation, leading to plasma membrane rupture and intracellular content release. Cancer immunotherapy, especially immune checkpoint inhibitors (ICIs) targeting PD-1 and PD-L1, has been considered a breakthrough in cancer treatment, achieving encouraging clinical anti-tumor effects in a variety of cancers. However, tumor immune evasion is indispensable to immunotherapy failure. The mechanisms of tumor immune evasion are quite complex, and its occurrence is inseparable from the ferroptosis in tumor microenvironment (TME). Thus, a comprehensive understanding of the role of ferroptosis in tumor immune evasion is crucial to enhance the efficacy of immunotherapy. In this review, we provide an overview of the recent advancements in understanding ferroptosis in cancer, covering molecular mechanisms and interactions with the TME. We also summarize the potential applications of ferroptosis induction in immunotherapy, as well as ferroptosis inhibition for cancer treatment in various conditions. We finally discuss ferroptosis as a double-edged sword, including the current challenges and future directions regarding its potential for cancer treatment.

1 January 2022 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
XWXianwei Wang
Xianwei Wang
JHJiaming Huang
Jiaming Huang
HHHaobo Hou
Haobo Hou
DCDong Chen
Dong Chen

5 July 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
TJTao Jiang
Tao Jiang
XWXianwei Wang
Xianwei Wang
JHJiaming Huang
Jiaming Huang
DCDong Chen
Dong Chen
Glioma is the worst prognostic neoplasm in the central nervous system. A polarity-regulating GTPase in cells, known as cell division cycle 42 (CdC42), has been proven to have its overactivation tightly connected to high tumor malignancy. The RNA-seq and protein expression of CDC42 in tumor and comparison tissues were analyzed based on the online tools; CDC42 was remarkably boosted in tumor tissues compared to normal controls. A total of 600 patients in the analysis set from The Cancer Genome Atlas (TCGA) database and 657 patients in the validation set from the Chinese Glioma Genome Atlas (CGGA) database were adopted. The expression of CDC42 in clinical features and biological functions of glioma was analyzed, including differential expression analysis, survival analysis, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and immune infiltration analysis. The enrichment of CDC42 was shown to be strongly associated with poor prognosis and terrible clinical indexes of glioma, including higher World Health Organization scale grade, wild-type isocitrate dehydrogenase 1 expression, O6-methylguanine-DNA methyltransferase non-methylated status, and 1p19q non-codeletion status (p < 0.0001). Functional enrichment analysis showed that CDC42 was highly correlated with immune and inflammatory responses in glioma. Additionally, the concentration extent of CDC42 was closely related to immune infiltration, immune checkpoints, and regulatory T (Treg) cell markers (CD4, CD25, and CD127). All evidence suggested that CDC42 may be a potential target for glioma immunotherapy.

9 July 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Open access
DCDong Chen
Dong Chen
LWLiding Wang
Liding Wang
TJTao Jiang
Tao Jiang
JHJiaming Huang
Jiaming Huang
MLMei Li
Mei Li
XWXianwei Wang
Xianwei Wang
Background: Various factors, including blood, inflammatory, infectious, and immune factors, can cause ischemic stroke. However, the primary cause is often the instability of cervical arteriosclerosis plaque. It is estimated that 18-25% of ischemic strokes are caused by the rupture of carotid plaque.1 1 Plaque stability is crucial in determining patient prognosis. Developing a highly accurate, non-invasive, or minimally invasive technique to assess carotid plaque stability is crucial for diagnosing and treating stroke.Previous research by our group has demonstrated that the expression levels of CHOP (C/EBP homologous protein) and GRP78 (glucose-regulated protein 78) are correlated with the stability of atherosclerotic plaques.2 2 Object: This research assesses changes in GRP78 and CHOP expressions in human umbilical vein endothelial cells (HUVEC) following experiments within the hemodynamic influencing factors test system. Additionally, it includes conducting an empirical study on the impact of blood flow shear force on the stability of human carotid atherosclerotic plaques. The objective is to explore the implications of blood flow shear force on the stability of carotid atherosclerotic plaques. Method: The hemodynamic influencing factors test bench system was configured with low (Group A, 4 dyns/ cm2), 2 ), medium (Group B, 8 dyns/cm2), 2 ), and high shear force groups (Group C, 12 dyns/cm2). 2 ). Relative expression levels of GRP78 and CHOP proteins in human umbilical vein endothelial cells were measured using Western blot analysis, and quantitative analysis of GRP78 and CHOP mRNA was conducted using RT-qPCR. Meanwhile, plaques from 60 carotid artery patients, retrieved via Carotid Endarterectomy (CEA), were classified into stable (S) and unstable (U) groups based on pathological criteria. Shear force at the carotid bifurcation was measured preoperatively using ultrasound. Western blot and RT-qPCR were used to analyze the relative expression levels of GRP78 and CHOP proteins and mRNA, respectively, in the plaque specimens from both groups. Result: Expression levels of GRP78, CHOP proteins, and their mRNAs were assessed in groups A, B, and C via Western blot and RT-qPCR. Results showed that in the low-shear group, all markers were elevated in group A compared to groups B and C. Statistical analysis revealed significantly lower shear forces at the carotid bifurcation in group U compared to group S. In group U plaques, GRP78 and CHOP expressions were significantly higher in group U than in group S. Conclusion: Blood flow shear forces variably affect the expression of GRP78 and CHOP proteins, as well as their mRNA levels, in vascular endothelial cells. The lower the shear force and fluid flow rate, the higher the expression of GRP78 and CHOP, potentially leading to endoplasmic reticulum stress(ERS), which may destabilize the plaque.

13 March 2025 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DCDong Chen
Dong Chen
XWXianwei Wang
Xianwei Wang
SZSen Zhang
Sen Zhang
JHJiaming Huang
Jiaming Huang
MLMei Li
Mei Li
TJTao Jiang
Tao Jiang

1 September 2023 in Gene
Verified
Journal Article
Closed access
TJTao Jiang
Tao Jiang
JHJiaming Huang
Jiaming Huang
SLShupeng Li
Shupeng Li
QXQiushi Xu
Qiushi Xu
TZTianding Zhang
Tianding Zhang
DCDong Chen
Dong Chen